Wilson M E, Hardin K K
Department of Internal Medicine, VA Medical Center, Iowa City, IA.
J Immunol. 1990 Jun 15;144(12):4825-34.
Two populations of Leishmania donovani chagasi promastigotes resistant to the lethal effects of tunicamycin (TM), an inhibitor of N-linked glycosylation, were raised. These parasites exhibited altered patterns of glycosylation when compared to wild-type controls. In particular the major surface glycoprotein gp63 was present in membranes of one population of TM-resistant promastigotes (population 1) primarily in a deglycosylated form, which migrated at a lower Mr than wild-type gp63. The deglycosylated protein was proteolytically inactive on substrate-containing gels, in contrast to glycosylated gp63. Assays of promastigote attachment to human macrophages revealed that, despite a proposed role for gp63 protease activity in binding to macrophage receptors, population 1 TM-resistant promastigotes appeared to attach to the CR3 but not to the mannose-fucose receptor. Control promastigotes bound to both receptors. In contrast, a second population of TM-resistant promastigotes (population 2) did not produce gp63 that could be detected on immunoblots, either in a glycosylated or deglycosylated form. The latter TM-resistant promastigotes bound to neither CR3 nor the mannose-fucose receptor, suggesting that expression of gp63 might be important for promastigotes to bind to CR3. LPG was present in immunoblots of both TM-resistant and control populations suggesting this molecule might not account for the differences in attachment. Surprisingly both TM-resistant promastigote populations contained gp63 mRNA by Northern analysis in apparently equal amounts. We conclude that N-glycosylation is probably necessary for the protease function of gp63, but that neither N-glycosylation nor protease activity of gp63 is necessary for L. donovani chagasi promastigotes to bind to CR3. Furthermore the expression of gp63 protein by TM-resistant promastigotes is dependent upon postranscriptional events.
培育出了两群对衣霉素(TM)(一种N - 连接糖基化抑制剂)的致死作用具有抗性的杜氏利什曼原虫恰加斯变种前鞭毛体。与野生型对照相比,这些寄生虫表现出糖基化模式的改变。特别是在一群对TM有抗性的前鞭毛体(群体1)的膜中,主要表面糖蛋白gp63主要以去糖基化形式存在,其迁移率低于野生型gp63。与糖基化的gp63相反,去糖基化蛋白在含底物的凝胶上没有蛋白水解活性。对前鞭毛体与人巨噬细胞附着的检测表明,尽管有人提出gp63蛋白酶活性在与巨噬细胞受体结合中起作用,但群体1对TM有抗性的前鞭毛体似乎附着于CR3而非甘露糖 - 岩藻糖受体。对照前鞭毛体与两种受体都结合。相比之下,第二群对TM有抗性的前鞭毛体(群体2)在免疫印迹上检测不到gp63,无论是糖基化还是去糖基化形式。后一群对TM有抗性的前鞭毛体既不与CR3也不与甘露糖 - 岩藻糖受体结合,这表明gp63的表达可能对前鞭毛体与CR3结合很重要。脂磷壁酸(LPG)在对TM有抗性的群体和对照群体的免疫印迹中都存在,表明该分子可能无法解释附着差异。令人惊讶的是,通过Northern分析,两群对TM有抗性的前鞭毛体都含有gp63 mRNA,且含量明显相等。我们得出结论,N - 糖基化可能是gp63蛋白酶功能所必需的,但gp63的N - 糖基化和蛋白酶活性对于杜氏利什曼原虫恰加斯变种前鞭毛体与CR3结合都不是必需的。此外,对TM有抗性的前鞭毛体中gp63蛋白的表达依赖于转录后事件。